Dermatitis

DERMATITIS

FEATURE ARTICLE

The Ongoing Challenges of Radiation-Induced Dermatitis

Linda Peckel

Jonathan Leventhal, MD, director of the Onco-Dermatology Program at Smilow Cancer Hospital, Yale-New Haven, explains prevention and treatment strategies for radiation-induced dermatitis (RID).

LATEST NEWS

Efficacy of Upadacitinib vs Dupilumab for Atopic Dermatitis

Emily Pond

The safety and efficacy of upadacitinib vs dupilumab in adults with atopic dermatitis is assessed.

Managing Itch in Atopic Dermatitis: Current and Potential Treatments

Colby Stong

Treatment options, recent advances in the field, and potential treatments for atopic dermatitis are reviewed.

Social Media May Be Effective for Recruiting Patients With Atopic Dermatitis

Colby Stong

Recruitment cost of participants with atopic dermatitis via social media and their characteristics are identified.

Severe Eczema Tied to Depression, Internalizing Behaviors in Children

Severe atopic dermatitis (AD) is associated with symptoms of depression and internalizing behaviors throughout childhood.

Relative Safety of Systemic Immunomodulatory Agents for Atopic Dermatitis

Emily Pond

The risk of bacterial and opportunistic infection in patients with AD treated with systemic immunomodulatory agents is assessed.

Readmission Rates and Comorbidity Index for Atopic Dermatitis Patients

Estie Mermelstein, MSN, FNP-BC

Longitudinal trends of 30-day readmissions of patients with atopic dermatitis are examined.

Atopic Dermatitis Improvements Seen in Very Young Treated With Dupilumab

Brian Park, PharmD

The phase 3 trial evaluated dupilumab, in addition to standard of care low potency topical corticosteroids, in 162 patients aged 6 months to 5 years with uncontrolled moderate to severe atopic dermatitis.